more info

Start date: 1 May 2017

End date: 1 November 2019

Number of projects: 3

Total budget: 7 608 159,54 €

EU contribution: 3 804 079,77 €

Website: n/a

Country:

European Commission Flag

Explore more: n/a

funds

ERDF: 3 804 079,77 €

ITALFARMACO S.P.A.

Beneficiary in Italy 00737420158

1 - 3 of 3

PROJECT

TOTAL BUDGET

EU CONTRIBUTION

FUND

DEVELOPMENT OF NEW SECOND GENERATION MOLECULES FOR CANCER IMMUNOTHERAPY

4 167 588,50 €

2 083 794,25 €

ERDF

ITFE-CKKER: NEW THERAPEUTIC APPROACH TO THE MUSCULAR DYSTROPHY OF BECKER (DMB)

3 019 973,00 €

1 509 986,50 €

ERDF

EPIGENETIC THERAPY FOR THE TREATMENT OF CORONAVIRUS INFECTIONS

420 598,04 €

210 299,02 €

ERDF